392 related articles for article (PubMed ID: 30300013)
1. The rise of transcutaneous drug delivery for the management of alopecia: a review of existing literature and an eye towards the future.
Wipf A; Boysen N; Hordinsky MK; Dando EE; Sadick N; Farah RS
J Cosmet Laser Ther; 2019 Aug; 21(5):247-254. PubMed ID: 30300013
[No Abstract] [Full Text] [Related]
2. The role of laser and energy-assisted drug delivery in the treatment of alopecia.
Balazic E; Muskat A; Kost Y; Cohen JL; Kobets K
Lasers Med Sci; 2024 Feb; 39(1):73. PubMed ID: 38381230
[TBL] [Abstract][Full Text] [Related]
3. A randomized, investigator-blinded, controlled, split-scalp study of the efficacy and safety of a 1550-nm fractional erbium-glass laser, used in combination with topical 5% minoxidil versus 5% minoxidil alone, for the treatment of androgenetic alopecia.
Suchonwanit P; Rojhirunsakool S; Khunkhet S
Lasers Med Sci; 2019 Dec; 34(9):1857-1864. PubMed ID: 30982177
[TBL] [Abstract][Full Text] [Related]
4. Topical 5% minoxidil versus combined erbium YAG laser and topical 5% minoxidil in androgenetic alopecia: A randomized controlled trial.
Mokhtari F; Zavare Z; Iraji F
J Cosmet Dermatol; 2023 Oct; 22(10):2737-2743. PubMed ID: 37574862
[TBL] [Abstract][Full Text] [Related]
5. Fractional Laser-assisted Hair Regrowth and Microneedling for the Treatment of Alopecia Areata: A Review.
Dabek RJ; Roh DS; Ozdemir D; Austen WG; Bojovic B
Cureus; 2019 Jun; 11(6):e4943. PubMed ID: 31453018
[TBL] [Abstract][Full Text] [Related]
6. Platelet-rich plasma in alopecia areata: intradermal injection versus topical application with transepidermal delivery via either fractional carbon dioxide laser or microneedling.
Ragab SEM; Nassar SO; Morad HA; Hegab DS
Acta Dermatovenerol Alp Pannonica Adriat; 2020 Dec; 29(4):169-173. PubMed ID: 33348935
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of combinational therapy using topical minoxidil and microneedling for the treatment of androgenetic alopecia: a systematic review and meta-analysis.
Abdi P; Awad C; Anthony MR; Farkouh C; Kenny B; Maibach HI; Ogunyemi B
Arch Dermatol Res; 2023 Dec; 315(10):2775-2785. PubMed ID: 37665358
[TBL] [Abstract][Full Text] [Related]
8. Translational medicine in the field of ablative fractional laser (AFXL)-assisted drug delivery: A critical review from basics to current clinical status.
Haedersdal M; Erlendsson AM; Paasch U; Anderson RR
J Am Acad Dermatol; 2016 May; 74(5):981-1004. PubMed ID: 26936299
[TBL] [Abstract][Full Text] [Related]
9. Androgenetic alopecia: an evidence-based treatment update.
Varothai S; Bergfeld WF
Am J Clin Dermatol; 2014 Jul; 15(3):217-30. PubMed ID: 24848508
[TBL] [Abstract][Full Text] [Related]
10. Comparative study between topical application of triamcinolone acetonide after fractional carbon dioxide laser versus microneedling in the treatment of resistant alopecia areata.
Omar MM; Obaid ZM; Sayedahmed OME
Dermatol Ther; 2022 Dec; 35(12):e15913. PubMed ID: 36209381
[TBL] [Abstract][Full Text] [Related]
11. Combined microneedling with topical vitamin D3 or bimatoprost versus microneedling alone in the treatment of alopecia areata: A comparative randomized trial.
Ali MS; Hafiz HSA; Ahmed NA; Galal SA
J Cosmet Dermatol; 2023 Apr; 22(4):1286-1296. PubMed ID: 36762396
[TBL] [Abstract][Full Text] [Related]
12. Microneedling for the treatment of hair loss?
Fertig RM; Gamret AC; Cervantes J; Tosti A
J Eur Acad Dermatol Venereol; 2018 Apr; 32(4):564-569. PubMed ID: 29194786
[TBL] [Abstract][Full Text] [Related]
13. Treatment of alopecia areata with nonablative fractional laser combined with topical minoxidil.
Wang W; Gegentana ; Tonglaga ; Bagenna ; Li Y
J Cosmet Dermatol; 2019 Aug; 18(4):1009-1013. PubMed ID: 31245963
[TBL] [Abstract][Full Text] [Related]
14. The Efficacy of Topical Minoxidil for Non-Scarring Alopecia: A Systematic Review.
Sung CT; Juhasz ML; Choi FD; Mesinkovska NA
J Drugs Dermatol; 2019 Feb; 18(2):155-160. PubMed ID: 30794366
[TBL] [Abstract][Full Text] [Related]
15. Fractional CO
Abd ElKawy FAE; Aly SHM; Ibrahim SMA
Dermatol Ther; 2022 Jul; 35(7):e15553. PubMed ID: 35509110
[TBL] [Abstract][Full Text] [Related]
16. Is methotrexate an effective and safe treatment for maintaining hair regrowth in people with alopecia totalis? A Critically Appraised Topic.
Browne R; Stewart L; Williams HC
Br J Dermatol; 2018 Sep; 179(3):609-614. PubMed ID: 29777625
[TBL] [Abstract][Full Text] [Related]
17. A Comparative Study of Microneedling with Platelet-rich Plasma Plus Topical Minoxidil (5%) and Topical Minoxidil (5%) Alone in Androgenetic Alopecia.
Shah KB; Shah AN; Solanki RB; Raval RC
Int J Trichology; 2017; 9(1):14-18. PubMed ID: 28761259
[TBL] [Abstract][Full Text] [Related]
18. Novel drug delivery approaches for the management of hair loss.
Alsalhi W; Alalola A; Randolph M; Gwillim E; Tosti A
Expert Opin Drug Deliv; 2020 Mar; 17(3):287-295. PubMed ID: 32003262
[No Abstract] [Full Text] [Related]
19. Randomized trial of electrodynamic microneedling combined with 5% minoxidil topical solution for treating androgenetic alopecia in Chinese males and molecular mechanistic study of the involvement of the Wnt/β-catenin signaling pathway.
Bao L; Zong H; Fang S; Zheng L; Li Y
J Dermatolog Treat; 2022 Feb; 33(1):483-493. PubMed ID: 32412314
[TBL] [Abstract][Full Text] [Related]
20. A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia.
Kumar MK; Inamadar AC; Palit A
J Cutan Aesthet Surg; 2018; 11(4):211-216. PubMed ID: 30886475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
